Therefore, up-regulation of CD80 may indicate T cell tolerance in the breast tumor microenvironment, CD80 has the potential to be used as a CD80/CD86–CTLA4 pathway blocking therapy. The gene discussed is CD86; the disease is breast neoplasm.